0 CHECKOUT

PRODUCT FILTERS

REGION

404
352
323
323
101

COUNTRY

100
90
87
85
85

CATEGORIES

  • 343
  • 201
  • 27
  • 15
  • 11
  • 11
  • 8
  • 6
  • 4
  • 3
  • 3
  • 3
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1

PRICE

1
1
11
608

PUBLISHED

51
201
323
608

PRODUCT TYPE

545
62
1

Search for: "Analysis of Emerging Cancer Diagnostic Tests and Strategic Profile of Leading Suppliers"

608 Products

2015 Analysis of Emerging Cancer Diagnostic Tests, and Strategic Profile of Leading Suppliers

This 286-page report presents comprehensive marketing and technological assessment, as well as medical rationale and diagnostic prospects, for the major categories of both circulating and cellular tests,...

Published:  January 2015
Price:  From

2014 Opportunities in the French Cancer Diagnostics Market (Datapack)

'2014 Opportunities in the French Cancer Diagnostics Market' is a new strategic analysis of the major business opportunities emerging in the cancer diagnostics market during the next five years The...

Published:  September 2013
Price: 

2014 Opportunities in the German Cancer Diagnostics Market (Datapack)

'2014 Opportunities in the German Cancer Diagnostics Market' is a new strategic analysis of the major business opportunities emerging in the cancer diagnostics market during the next five years The...

Published:  September 2013
Price: 

2014 Opportunities in the Japanese Cancer Diagnostics Market (Datapack)

'2014 Opportunities in the Japanese Cancer Diagnostics Market' is a new strategic analysis of the major business opportunities emerging in the cancer diagnostics market during the next five years The...

Published:  September 2013
Price: 

2014 Market Segmentation Analysis of the German Cancer Diagnostics Industry: Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Hospitals, Commercial Labs and Physician Offices

“2014 Market Segmentation Analysis of the German Cancer Diagnostics Industry: Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Hospitals, Commercial Labs,...

Published:  July 2014
Price:  From

2014 Market Segmentation Analysis of the UK Cancer Diagnostics Industry: Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Hospitals and Commercial Labs

“2014 Market Segmentation Analysis of the UK Cancer Diagnostics Industry: Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Hospitals, Commercial Labs, POC...

Published:  July 2014
Price:  From

2014 Market Segmentation Analysis of the US Cancer Diagnostics Industry: Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Hospitals, Commercial Labs, POC Locations

“2014 Market Segmentation Analysis of the US Cancer Diagnostics Industry: Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Hospitals, Commercial Labs, POC...

Published:  July 2014
Price:  From

2015-2019 World Cancer Diagnostics Market: Emerging Tests, Technology Assessment, Instrumentation Review, Country Sales Forecasts, and Strategic Profiles of Leading Suppliers

This new report provides analysis of the global cancer diagnostics market, including emerging tests, technologies, instrumentation, sales forecasts by country, and strategic profiles of leading suppliers....

Published:  June 2015
Price:  From

2015-2019 World Cancer Diagnostics Market: Emerging Tests, Technology Assessment, Instrumentation Review, Sales Forecasts by Country and Strategic Profiles of Leading Suppliers

This new report provides analysis of the global cancer diagnostics market, including emerging tests, technologies, instrumentation, sales forecasts by country, and strategic profiles of leading suppliers....

Published:  July 2015
Price:  From

2015 World Cancer Diagnostics Market: Emerging Tests, Technology Assessment, Instrumentation Review, Sales Forecasts by Country and Strategic Profiles of Leading Suppliers

This new report provides analysis of the global cancer diagnostics market, including emerging tests, technologies, instrumentation, sales forecasts by country, and strategic profiles of leading suppliers. The...

Published:  April 2015
Price:  From

World Cancer Diagnostics Market 2014: Emerging Tests, Technology Assessment, Instrumentation Review, Sales Forecasts by Country and Strategic Profiles of Leading Suppliers

This new report from the author provides analysis of the global cancer diagnostics market, including emerging tests, technologies, instrumentation, sales forecasts by country, and strategic profiles...

Published:  January 2014
Price:  From

2014 Opportunities in the Spanish Cancer Diagnostics Market (Datapack)

'2014 Opportunities in the Spanish Cancer Diagnostics Market' is a new strategic analysis of the major business opportunities emerging in the cancer diagnostics market during the next five years The...

Published:  September 2013
Price: 

2014 Market Segmentation Analysis of the Italian Cancer Diagnostics Industry: Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Hospitals and Commercial Labs

“2014 Market Segmentation Analysis of the Italian Cancer Diagnostics Industry: Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Hospitals, Commercial Labs,...

Published:  July 2014
Price:  From

2014 Market Segmentation Analysis of the French Cancer Diagnostics Industry: Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Hospitals and Commercial Labs

“2014 Market Segmentation Analysis of the French Cancer Diagnostics Industry: Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Hospitals, Commercial Labs,...

Published:  July 2014
Price:  From

2014 Market Segmentation Analysis of the Japanese Cancer Diagnostics Industry: Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Hospitals and Commercial Labs

“2014 Market Segmentation Analysis of the Japanese Cancer Diagnostics Industry: Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Hospitals, Commercial Labs,...

Published:  July 2014
Price:  From

2014 Market Segmentation Analysis of the Spanish Cancer Diagnostics Industry: Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Hospitals and Commercial Labs

“2014 Market Segmentation Analysis of the Spanish Cancer Diagnostics Industry: Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Hospitals, Commercial Labs,...

Published:  July 2014
Price:  From

2014 Opportunities in the Italian Cancer Diagnostics Market (Datapack)

'2014 Opportunities in the Italian Cancer Diagnostics Market' is a new strategic analysis of the major business opportunities emerging in the cancer diagnostics market during the next five years The...

Published:  September 2013
Price: 

2014 Opportunities in the UK Cancer Diagnostics Market (Datapack)

'2014 Opportunities in the UK Cancer Diagnostics Market' is a new strategic analysis of the major business opportunities emerging in the cancer diagnostics market during the next five years The report...

Published:  September 2013
Price: 

Future Horizons and Growth Strategies in the German Cancer Diagnostics Market 2015: Supplier Shares and Country Forecasts

Future Horizons and Growth Strategies in the German Cancer Diagnostics Market 2015” is a new strategic analysis of the major business opportunities emerging in the cancer diagnostics market during the...

Published:  June 2015
Price:  From

2015-2019 UK Cancer Diagnostics Market: Supplier Shares, Country Forecasts, Innovative Technologies, Competitive Strategies

2015-2019 UK Cancer Diagnostics Market” is a new strategic analysis of the major business opportunities emerging in the cancer diagnostics market during the next five years.  The report examines trends...

Published:  June 2015
Price:  From
Loading Indicator

Our Clients

  • Amneal Pharmaceuticals LLC.
  • Amgen Inc.
  • LEO Laboratories Ltd.
  • Pfizer, Inc.
  • Roche Diagnostics Ltd.
  • Merck & Co., Inc.
  • Sanofi S.A.